ABSTRACT Background: The Food Insulin Index (FII) is a novel classification of single foods based on insulin responses in healthy subjects relative to an isoenergetic reference food. Objective: Our aim was to compare day-long responses to 2 nutrientmatched diets predicted to have either high or low insulin demand in healthy controls and individuals with type 2 diabetes (T2DM). Design: Twenty adults (10 healthy adults and 10 adults with T2DM) were recruited. On separate mornings, subjects consumed either a high-or low-FII diet in random order. Diets consisted of 3 consecutive meals (breakfast, morning tea, and lunch), matched for macronutrients, fiber, and glycemic index (GI), but with 2-fold difference in insulin demand as predicted by the FII of the component foods. Postprandial glycemia and insulinemia were measured in capillary plasma at regular intervals over 8 h. Results: As predicted by their GI, there were no differences in glycemic responses between the 2 diets in either group (mean 6 SEM; healthy: 6.2 6 0.2 compared with 6.1 6 0.1 mmol/L $ min, P = 0.429; T2DM: 9.9 6 1.3 compared with 10.3 6 1.6 mmol/L $ min, P = 0.485). Compared with the high-FII diet, mean postprandial insulin response over 8 h was 53% lower with the low-FII diet in healthy subjects (mean 6 SEM; incremental AUC insulin 31,900 6 4100 pmol/L $ min compared with 68,100 6 11,400 pmol/L $ min, P = 0.003) and 41% lower in subjects with T2DM (mean 6 SEM; incremental AUC insulin 11,000 6 1800 pmol/L $ min compared with 18,700 6 3100 pmol/L $ min, P = 0.018). Incremental AUC insulin was statistically significantly different between diets when groups were combined (P = 0.001). Conclusions: The FII algorithm may be a useful tool for reducing postprandial hyperinsulinemia in T2DM, thereby potentially improving insulin resistance and b-cell function. This trial was registered at the Australian New Zealand Clinical Trials Registry as ACTRN12611000654954.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) 4 is characterized by chronic hyperglycemia resulting from insulin resistance and b-cell failure. Insulin resistance is linked to chronic hyperinsulinemia, which in turn may induce oxidative stress and exacerbate b-cell dysfunction (1) . Dietary patterns that induce excessive insulin secretion have been associated with weight gain (2) and a higher risk of developing T2DM (3) .
Conventional diet therapy for T2DM is based on improving insulin sensitivity, primarily through weight loss, and reducing postprandial hyperglycemia by manipulating carbohydrate amount, type, and distribution over the day (4) . However, protein and fat have also been shown to be potent modulators of insulin secretion in both healthy subjects and those with T2DM (5) .
The Food Insulin Index (FII) is a novel classification for ranking foods based on their physiologic insulin demand relative to an isoenergetic reference food in healthy subjects (6) . In single food studies, the FII has been shown to be a better predictor of observed insulin responses than the carbohydrate content or glycemic index (GI) (7) . However, whether the FII can predict the day-long glucose and insulin responses in the context of realistic mixed meals has yet to be seen. Furthermore, the FII may not be relevant in individuals with T2DM because b-cell function and insulin secretion are compromised. The aim of the present study, therefore, was to determine whether the FII could predict daylong metabolic responses in healthy individuals and adults with T2DM, consuming 3 consecutive meals that had similar macronutrient content but a 2-fold difference in insulin demand, as predicted by the FII of the component foods. We hypothesized that despite the same carbohydrate content, fiber, and GI, there would still be a large difference in insulin responses within both groups.
METHODS
Ten lean healthy adults and 11 adults with T2DM were recruited for this randomized, crossover study. Volunteers with T2DM were included if they were well controlled by diet or oral hypoglycemic agents. They were ineligible if they used insulin therapy, had food allergies or intolerances, or were not proficient in English. There was no BMI (in kg/m 2 ) inclusion criteria for T2DM subjects. The study was approved by the University of Sydney Human Research Ethics Committee and registered with the Australian New Zealand Clinical Trials Registry as ACTRN12611000654954. Participants gave written, informed consent.
Subjects presented to the metabolic kitchen at the University of Sydney after an 8-h overnight fast. On the day before each test session, they were instructed to consume a high-carbohydrate, low-fat dinner; avoid alcohol and legumes; and maintain usual physical activity levels. On 2 separate test days, they consumed a high-FII and a low-FII diet in random order, consisting of 3 consecutive meals over an 8-h period (i.e., breakfast, morning tea, and lunch given at w0800, 1100, and 1300 h, respectively). The order of the diets was determined by using a computer-generated randomization sequence before recruitment and sealed in opaque envelopes. The 2 diets were matched for energy, macronutrients, fiber, and GI but had a 2-fold difference in predicted insulin demand ( Table 1) . Capillary blood samples were taken every 30-60 min, with a total of 13 blood samples taken per test day. Plasma glucose was analyzed with the glucose hexokinase enzymatic assay on a centrifugal analyzer (Model Hitachi 912; Hitachi), and plasma insulin was measured by antibody-coated tube radioimmunoassay (Diagnostic Products Corporation).
A sample size was estimated based on previous data suggesting 10 subjects were needed to detect one SD difference in insulin incremental AUC, with P , 0.05 (unpublished data). Data are presented as means 6 SEMs unless otherwise indicated. The primary outcome measure was the change in incremental AUC across the 8-h period for insulin, which was calculated according to the trapezoidal rule with fasting level (time 0) as the baseline and the area beneath the fasting level ignored (8) . The secondary outcome measures were changes in 8-h incremental AUC for glucose and changes in mean postprandial glucose and insulin over 8 h. Student's 2-tailed t test for paired data was applied to determine statistical differences between the diets within each group. A mixed ANOVA was applied for both incremental AUC insulin and incremental AUC glucose to assess any diet 3 group interaction. A post hoc paired t test was conducted to further explore significant interactions. Differences were considered significant if the 2-tailed P , 0.05 and highly significant if P , 0.001. Statistical analysis was performed with SPSS version 22 (SPSS, Inc.).
RESULTS
All participants except one completed the protocol. Healthy subjects (n = 10, 6 male) had a mean 6 SD age of 22 6 3 y and a mean 6 SD BMI of 22.8 6 2.4. Those with T2DM (n = 10, 6 male) had a mean 6 SD age of 63 6 10 y and a mean 6 SD BMI of 29.6 6 2.0. Seven of these subjects were taking metformin, 1 subject was taking metformin/sitagliptin, and 3 subjects were diet controlled. One subject with T2DM withdrew because of difficulty with capillary blood sampling. Within each group, fasting plasma glucose and insulin concentrations were similar on both days but were notably higher in T2DM subjects, reflecting hepatic insulin resistance (Figures 1  and 2 , Table 2 ). As predicted by the GI of the meals, there was no significant difference in the plasma glucose incremental AUC over 8 h to the low-and high-FII diets in either group (healthy: 387 6 70 compared with 360 6 88 mmol/L $ min, P = 0.73; T2DM: 840 6 230 compared with 880 6 230 mmol/L $ min respectively, P = 0.994). Similarly, there were no significant differences in the mean plasma glucose concentration across 8 h (healthy: 6.2 6 0.2 compared with 6.1 6 0.1 mmol/L $ min, P = 0.429; T2DM: 9.9 6 1.3 compared with 10.3 6 1.6 mmol/L $ min, P = 0.485).
As predicted, the observed insulin response to the low-FII diet was significantly lower than that of the high-FII diet. The mean postprandial insulin incremental AUC for the low-compared with high-FII diet was 53% lower in the healthy subjects (31,900 6 4100 vs 68,100 6 11,400 mmol/L $ min, P = 0.003) and 41% lower in subjects with T2DM (11,000 6 1800 compared with 18,700 6 3100 mmol/L $ min, P = 0.018; Figure 2 and Table 2 ). The observed insulin response difference in healthy adults was almost identical to the calculated insulin demand evoked by 2 diets using the FII of the component foods (low-FII diet: FII = 30, which is 54% less than the high-FII diet: FII = 65).
There was a significant diet 3 group effect on postprandial insulin incremental AUC (P = 0.002) but not for postprandial glucose incremental AUC (P = 0.745). A post hoc paired t test revealed that there were significant differences in the incremental AUC for insulin between groups on each diet (low FII: P = 0.013; high FII: P = 0.003), with an incremental AUC higher in healthy subjects. When healthy and T2DM subjects were combined, there was still a highly significant difference between the 2 diets (mean difference: 22,780 pmol/L $ min, P = 0.001).
DISCUSSION
This study provides the first evidence of the physiologic validity of the FII in a realistic setting. The concept was evaluated in the context of 3 consecutive mixed meals in lean, healthy adults and individuals with T2DM. The findings in healthy adults show that a 2-fold difference in the predicted insulin demand (based on the FII of the component foods) translates to an almost identical difference in the mean postprandial incremental AUC for insulin over 8 h, even when macronutrients, fiber, GI, and glycemia were matched between the 2 diets. Although it could be postulated that the FII concept would not be applicable to individuals with T2DM due to insulin resistance and b-cell dysfunction, we achieved a similar relative reduction in insulin response in this group, suggesting that a low-FII diet can reduce nutrient-induced hyperinsulinemia in T2DM.
Carbohydrate, protein, and fat have been shown to be potent stimuli for insulin secretion, although varying in their efficacy and mode of action (5). Therefore, the 2 diets employed in this study were carefully matched for macronutrients, fiber, and GI to rule out differences in glycemic and insulinemic responses due to FIGURE 1 Mean plasma glucose profile after a high-FII and low-FII diet over 8 h in lean healthy adults (A; n = 10, P = 0.730) and adults with noninsulin-treated T2DM (B; n = 10, P = 0.994). Comparisons within groups were analyzed by Student's 2-tailed t test for paired data. FII, Food Insulin Index; T2DM, type 2 diabetes mellitus. macronutrient composition. The 2-fold difference in insulin demand was achieved by varying the food sources (ingredients) according to their insulin demand as predicted by the FII.
On an isoenergetic basis, protein-rich foods incorporated in the high-FII diet, including milk, yogurt, cheese, and baked beans, produce an insulin response more than twice that of other protein sources incorporated into the low-FII diet, such as roast chicken and walnuts. Although almost all protein sources have been shown to exert an insulinotropic effect, certain proteins and amino acids, including glutamine, alanine, and arginine, have been shown to modulate insulin response and insulin action, increasing insulin secretion by .200% (5, 9, 10).
Dietary fat by itself does not initiate insulin secretion but nonetheless acutely amplifies glucose-stimulated insulin secretion (11, 12) . Collier et al. (12) showed that the addition of 37.5 g fat to 75 g carbohydrate resulted in a w60% greater insulin response than with the carbohydrate meal alone. The authors proposed that this was potentially due to increased pancreatic FIGURE 2 Mean plasma insulin profile after a high-FII and low-FII diet over 8 h in lean healthy adults (A; n = 10, P = 0.003) and adults with non-insulintreated T2DM (B; n = 10, P = 0.018). Comparisons within groups were analyzed by Student's 2-tailed t test for paired data. FII, Food Insulin Index; T2DM, type 2 diabetes mellitus. insulin release combined with increased incretin hormone release. The potency of fatty acids on insulin secretion is directly correlated with the fatty acid chain length and degree of saturation, with long-chain unsaturated fatty acids increasing insulin secretion (13, 14) . Although acute exposure (1-3 h) of pancreatic b cells to free fatty acid enhances insulin secretion, longterm exposure (6-24 h) to high free fatty acid concentrations desensitizes the b cell, impairs glucose-stimulated insulin release, and thus suppresses insulin secretion (5, 15, 16) .
As anticipated by matching carbohydrate and GI, there were no significant differences in the glycemic responses between the 2 diets in either group. Hence, differences in glycemia were not responsible for the observed differences in insulinemic responses. The effect can therefore be attributed to different types of fat and protein, which by themselves have no immediate effect on plasma glucose concentrations yet have profound effects on insulin secretion, glucose metabolism, and gluconeogenesis (17) . This is a physiologically important phenomenon because insulin is required for the metabolism of carbohydrate, protein, and fat and naturally secreted in response to ingestion. To prevent blood glucose concentrations from falling as insulin secretion increases, metabolism of amino acids in the pancreatic b cells also triggers glucagon release (10) . This hormone acts in opposition to insulin, increasing hepatic glucose output to maintain blood glucose concentrations within the normal range. We can therefore predict that the glucagon response would differ in the late postprandial period. It would be informative to measure glucagon and other glucoregulatory hormones, such as glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide, in future studies to confirm this.
Although the FII values are generated by testing healthy subjects (18) , this study suggests the FII can be extrapolated to those with T2DM, with the potential to improve metabolic control by reducing insulin demand. Previous studies have shown the insulin response to protein is as much as w4-fold greater in people with T2DM than that of healthy subjects (19) . In our study, the incremental response to food ingestion was much less in those with T2DM, likely reflecting compromised b-cell function and reduced b-cell mass. Despite these metabolic differences between healthy and T2DM subjects, our findings show that the relative difference in insulin demand between foods sources is similar, and thus the FII is still applicable in this population.
With further research, the FII could prove to be a useful tool for optimizing the postprandial insulinemia, targeting the overall normal physiologic insulin response and promoting foods with a lower "insulin demand." The findings are therefore relevant to prevention as well as management of T2DM. From a consumer perspective, it is also a more holistic and practical approach, because it focuses on whole foods, rather than specific macronutrients within foods. However, knowledge of the relative FII of foods is required to translate this information into everyday food choices. In practice, it would be important to consider the serving size of food consumed, not just the "relative" insulin demand of the food (as predicted by its FII). A large serving of a low-FII food can be expected to produce an insulin response comparable to that of a small portion of a high-FII food. "Insulin demand" calculated from usual portion size and FII could be generated.
The strengths of this study include the careful selection of foods and macronutrients so that the only difference was the predicted insulin response. Blood samples were taken frequently (30-min intervals), and a standard protocol was followed. Nonetheless, our study was conducted in adults with T2DM who did not require insulin and may not be generalizable to those with poor control, using different pharmacologic treatments, or with more compromised pancreatic function. Relative insulinemic responses will therefore be influenced by the duration of diabetes and vascular complications and should be assessed in older and more compromised individuals. The utility of the FII also needs to be explored in adults with prediabetes with impaired fasting glucose and/or impaired glucose tolerance and with varying degrees of insulin resistance.
The FII may also be relevant to obesity. Nimptsch et al. (20) investigated the average dietary FII and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. After multivariate adjustment, participants in the highest quintile of FII had 26% higher triglyceride concentrations than did participants in the lowest quintile of FII (P-trend , 0.0001). This association was strongest in obese participants. Dietary FII was inversely associated with HDL cholesterol in obese participants (difference: 218%; P-trend = 0.03). However, dietary FII and insulin load were not significantly associated with plasma C-peptide, glycated hemoglobin, LDL cholesterol, or C-reactive protein. Further research is warranted to determine whether the results can be translated to clinically meaningful improvements in metabolic control in free-living adults over a longer period.
In summary, a low-FII diet produced predictably lower daylong insulin responses compared with a high-FII diet in both healthy adults and those with T2DM, even when the diets were matched for macronutrients, fiber, and GI. The FII algorithm may therefore be a useful dietary strategy for the prevention and treatment of T2DM, by reducing the postprandial insulin demand and thus potentially reducing insulin resistance and preserving b-cell function.
The authors' responsibilities were as follows-KJB, JB, SC, and JCB-M: conceived the study; KJB and JB: conducted the study; KJB, JB, PP, and JCB-M: analyzed or interpreted data; KJB, JB, and JCB-M: wrote the manuscript. All authors contributed to the discussion of the manuscript. JCB-M and SC are coauthors of lay books about the glycemic index of foods. JCB-M is a director of the Glycemic Index Foundation, a not-for-profit company that administers a food endorsement program based on the glycemic index of foods. KJB, JB, and PP declared no duality of interest associated with their contribution to this article.
